Merck Millipore holds vaccine technology seminar in South Korea

•

0 gostou•499 visualizações

Merck Millipore holds vaccine technology seminar at Seoul, South Korea.

Mais conteúdo relacionado

Accelerating vaccine development and manufacturingDr. Priyabrata Pattnaik

Overcoming challenges of host cell DNA removal in vaccine manufacturingDr. Priyabrata Pattnaik

Best Practices in Nucleic Acid Removal from Vaccine ProcessesDr. Priyabrata Pattnaik

Pragmatic implementation of single use technologies to deliver clinical supplyDr. Priyabrata Pattnaik

Viral-vectored vaccines: a new approach in the vaccine manufacturing processDr. Priyabrata Pattnaik

VacChina 2011 Opening RemarkDr. Priyabrata Pattnaik

Use of single-use technology in Aseptic processing of vaccines: Application s...Dr. Priyabrata Pattnaik

Accelerating vaccine development and manufacturing

Overcoming challenges of host cell DNA removal in vaccine manufacturing

Best Practices in Nucleic Acid Removal from Vaccine Processes

Pragmatic implementation of single use technologies to deliver clinical supply

Viral-vectored vaccines: a new approach in the vaccine manufacturing process

VacChina 2011 Opening Remark

Use of single-use technology in Aseptic processing of vaccines: Application s...

1. OUTLET: Digital Times, South Korea; DATE: Mar. 14, 2014; HEADLINE: “한국 백신 자력조달 돕겠다”